Zhao Chao, deputy to the National Peoples Congress, suggested speeding up the reappraisal of traditional Chinese medicine injections

category:Global
 Zhao Chao, deputy to the National Peoples Congress, suggested speeding up the reappraisal of traditional Chinese medicine injections


Zhao Chao, deputy to the National Peoples Congress and President of Step-size Pharmaceuticals. Photo Source/Information Picture

On the morning of March 5, the second session of the 13th National Peoples Congress opened. Premier Li Keqiang of the State Council pointed out in the government work report that he supported the inheritance, innovation and development of traditional Chinese medicine. Zhao Chao, deputy to the National Peoples Congress and President of Step-length Pharmaceuticals, also indicated at the Symposium of CPPCC Members of the National Peoples Congress of the Peoples Congress of the Chinese Medical Industry in 2019, that the development of traditional Chinese medicine is still facing many challenges due to the fact that the modern management and development system of traditional Chinese medicine which conforms to the characteristics of traditional Chinese medicine has not yet been established. It is suggested that the large varieties of traditional Chinese medicine with Re-evaluation of traditional Chinese medicine injection.

The management and development system of modern Chinese medicine still needs to be established

In recent years, several national strategic development plans of TCM, such as the Health Service Development Plan of TCM and the Outline of the Strategic Development Plan of TCM, have been issued one after another, and the Law of TCM has been formally implemented on July 1, 2017. According to Zhao Chao, deputy to the National Peoples Congress and President of Step Pharmaceutical, the development of traditional Chinese medicine is facing many challenges while welcoming many favorable policies.

On the one hand, the modern management and development system of traditional Chinese medicine which conforms to the characteristics of traditional Chinese medicine has not been established. Although the clinical value of traditional Chinese medicine is very important, it will not be recognized by doctors and patients for thousands of years if we do not seriously study and develop the theories and methods of traditional Chinese medicine and formulate the management system and evaluation methods that conform to the characteristics of traditional Chinese medicine. On the other hand, the long chain of traditional Chinese medicine industry, quality and efficacy are not only restricted by the manufacturing process, but also by the source of raw materials and the cultivation and breeding environment, picking, processing, storage, processing and other processes. Current management and development methods are not in line with the characteristics of traditional Chinese medicine.

Not only that, the evaluation of traditional Chinese medicine by western medicine is also in urgent need of standard and norms. Chinese medicine is still the most widely used variety in clinic. A lot of safety and validity studies have been carried out by referring to the research and evaluation methods of Western medicine. After many large varieties of Chinese medicine injections have been listed, the related research and development costs far exceed the later investment after the international advanced enterprising drugs have been listed. However, the re-evaluation scheme of Chinese medicine of relevant national departments has not yet been published.

In addition, the management of rational drug use and medical insurance payment focuses on traditional Chinese medicine. At present, the unreasonable rapid growth of medical expenses and the imperfect compensation mechanism of existing medical system and hospitals should be the main reasons. In the process of rational drug use management in medical and health departments, Chinese patent medicines have become the main object of monitoring and restricting the use of Chinese patent medicines because of the large sales volume of enterprises and the fact that they are not fully recognized by the evaluation methods of Western medicines as Western medicines. In the 2017 edition of the national health insurance catalogue, 26 traditional Chinese medicine injections are limited to use in secondary or higher medical institutions, or to severe treatment.

Strengthen the Training of Traditional Chinese Medicine Doctors and Accelerate the Re-evaluation of Traditional Chinese Medicine Injections

Zhao Chao put forward four suggestions, such as establishing an evaluation system and mechanism in line with the characteristics of traditional Chinese medicine as soon as possible, strengthening and perfecting the management and development mechanism of the whole production chain of traditional Chinese medicine, etc.

First, the combination of traditional Chinese medicine and Western medicine is a clinical necessity, there is no primary or secondary difference. It is necessary to treat large varieties of Chinese medicines with large clinical dosage scientifically, so as to avoid the misuse of auxiliary medicines due to the conclusive clinical efficacy and large dosage of Chinese medicines.

Third, scientific evaluation and rational treatment of traditional Chinese medicine injections, speed up the re-evaluation of traditional Chinese medicine injections. Traditional Chinese medicine injection is the product of the combination of modern pharmaceutical technology and traditional Chinese medicine. It is a significant innovation in the process of modernization of traditional Chinese medicine. In the past 20 years, a number of powerful and responsible Chinese medicine enterprises have introduced advanced pharmaceutical technology through cooperation with institutions of higher learning. The quality of traditional Chinese medicine injections has been greatly improved. At the same time, clinical safety evaluation research has been carried out, which provides more and more scientific evidence of clinical efficacy and adverse reactions. The mechanism of action has been gradually deepened, and the quality of traditional Chinese medicine injections and the scope of clinical application in enterprises have been strengthened.

Fourth, establish an independent evaluation system of traditional Chinese medicine. The current clinical drug evaluation system of TCM innovation does not fully respect the theoretical system and important characteristics of TCM, but basically refers to the clinical evaluation system and guiding standards of Western medicine. Establish the diagnostic criteria, evaluation techniques and methods of clinical symptoms of TCM, application and research of TCM pharmacy, establish animal models that accord with the clinical dialectical characteristics of TCM, establish the techniques and methods of evaluation of TCM symptoms in animal models, and construct a unique evaluation system of TCM pharmacy that reflects the clinical efficacy and action characteristics of TCM.